Blockchain Registration Transaction Record

Annovis Bio (NYSE: ANVS) Makes Strides in Neurodegenerative Disease Research with New Patent Filing

Annovis Bio (ANVS) files new composition of matter patent for buntanetap, marking a significant milestone in the fight against neurodegenerative diseases.

Annovis Bio (NYSE: ANVS) Makes Strides in Neurodegenerative Disease Research with New Patent Filing

This news matters as it signifies a major breakthrough in the research and development efforts to address the unmet medical needs related to Alzheimer’s disease, Parkinson’s disease, and other neurodegenerative conditions.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0xe03b097c8292901a81b72e51e504f9750022eb5c694823efda04af501129bc57
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintpavehQu_-da7a60825911925333ecf03e1e696122